IL15 and plasma cell myeloma: ALT-803, a fusion complex of IL15 and IL15RA receptor, exhibited a more substantial tumor-killing effect than native IL15 in preclinical models of myeloma through promoting the proliferation of CD8 memory T cells and inducing large amounts of IFN-γ (205).